ATHE Insider Trading Activity and SEC Form 4 Filings
ATHE insider trading summary
Over the past 12 months, insiders at Alterity Therapeutics Ltd (ATHE) reported 1 open-market purchase worth $24K by 1 insider and no sales on SEC Form 4. Net insider buying was $24K.
Latest ATHE insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 31, 2026 | Peter Ashley Marks | Director | Buy | $24K (47,620 @ $0.50) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.